Diphtheria-tetanus-acellular pertussis vaccine safety in children under 7 years: a post-marketing analysis of the U.S. vaccine adverse event reporting system. [PDF]
Liu M +6 more
europepmc +1 more source
Diphtheria and pertussis outbreaks in the Americas: a scoping review of epidemiology, vaccination trends and control strategies, 2013-2024. [PDF]
Jean Baptiste AE +6 more
europepmc +1 more source
Safety and health-related quality of life following maternal respiratory syncytial virus (RSV) and diphtheria-tetanus-acellular pertussis (DTaP) vaccinations. [PDF]
Kitano T +12 more
europepmc +1 more source
Safety and immunogenicity of diphtheria, tetanus and pertussis (acellular, three components) combined vaccine, adsorbed after three-dose priming in 2 months age infants: a randomized, blinded, controlled phase III clinical trial in China. [PDF]
Zhang W +16 more
europepmc +1 more source
Seroprevalence of diphtheria, tetanus, pertussis among healthcare workers (HCWs) - A cross-sectional study at the National Centre for Infectious Diseases and Tan Tock Seng Hospital, Singapore. [PDF]
Lim DW +12 more
europepmc +1 more source
Maternal Vaccine Receipt and Infant Hospital and Emergency Visits for Influenza and Pertussis. [PDF]
Morabito G +4 more
europepmc +1 more source
Replacing ADT With dTpa in Queensland Emergency Departments: Another Opportunity for Pertussis Control? [PDF]
Nissen MD +4 more
europepmc +1 more source
Immunogenicity and safety of co-purified diphtheria, tetanus and acellular pertussis vaccine in 6-year-old Chinese children. [PDF]
Tang X +16 more
europepmc +1 more source
Long-term impact of the COVID-19 pandemic on childhood vaccination coverage in Quebec, Canada: A cohort study from the Canadian immunization research network. [PDF]
Kiely M +6 more
europepmc +1 more source
Application of the WHO new vaccine introduction prioritisation and sequencing framework to guide evidence-based vaccine introduction decisions in Iran, 2025-2030. [PDF]
Fotouhi A +19 more
europepmc +1 more source

